Healius Ltd Asset Resilience Ratio

Latest as of December 2015: 0.06%

Healius Ltd asset resilience ratio. Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HLS defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$2.43 Million
≈ $1.72 Million USD Cash + Short-term Investments

Total Assets

AU$3.91 Billion
≈ $2.77 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Healius Ltd (2002–2017)

Asset resilience ratio of Healius Ltd from 2002 to 2017. This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. Read Healius Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Healius Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$2.43 Million 0.06%
Total Liquid Assets AU$2.43 Million 0.06%

Asset Resilience Insights

  • Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Healius Ltd Industry Peers by Asset Resilience Ratio

Compare Healius Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Voxel S.A.
WAR:VOX
Diagnostics & Research 0.32%
Leveljump Healthcare Corp
V:JUMP
Diagnostics & Research 32.45%
Prodia Widyahusada Tbk PT
JK:PRDA
Diagnostics & Research 7.82%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%
Australian Clinical Labs Ltd
AU:ACL
Diagnostics & Research 4.11%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Cryosite Ltd
AU:CTE
Diagnostics & Research 5.65%

Healius Ltd Asset Resilience Ratio by Year (2002–2017)

Healius Ltd asset resilience ratio by year from 2002 to 2017. The table below shows the annual Asset Resilience Ratio data for Healius Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-06-30 0.00% AU$0.00
≈ $0.00
AU$3.11 Billion
≈ $2.20 Billion
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$3.62 Billion
≈ $2.56 Billion
--
2015-06-30 0.08% AU$3.20 Million
≈ $2.26 Million
AU$3.92 Billion
≈ $2.77 Billion
-0.04pp
2012-06-30 0.12% AU$4.57 Million
≈ $3.24 Million
AU$3.86 Billion
≈ $2.73 Billion
+0.10pp
2011-06-30 0.02% AU$798.00K
≈ $564.64K
AU$3.83 Billion
≈ $2.71 Billion
-0.02pp
2010-06-30 0.04% AU$1.50 Million
≈ $1.06 Million
AU$3.70 Billion
≈ $2.62 Billion
-0.14pp
2009-06-30 0.18% AU$6.93 Million
≈ $4.91 Million
AU$3.78 Billion
≈ $2.67 Billion
+0.18pp
2008-06-30 0.00% AU$115.00K
≈ $81.37K
AU$4.80 Billion
≈ $3.40 Billion
-0.02pp
2007-06-30 0.02% AU$135.00K
≈ $95.52K
AU$606.50 Million
≈ $429.14 Million
+0.02pp
2002-06-30 0.00% AU$-6.00K
≈ $-4.25K
AU$283.35 Million
≈ $200.49 Million
--
pp = percentage points

About Healius Ltd

AU:HLS Australia Diagnostics & Research
Market Cap
$254.33 Million
AU$359.45 Million AUD
Market Cap Rank
#15350 Global
#406 in Australia
Share Price
AU$0.50
Change (1 day)
+2.06%
52-Week Range
AU$0.32 - AU$1.04
All Time High
AU$4.91
About

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more